These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 25226305)

  • 1. In vitro drug release of natamycin from β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin-functionalized contact lens materials.
    Phan CM; Subbaraman LN; Jones L
    J Biomater Sci Polym Ed; 2014; 25(17):1907-19. PubMed ID: 25226305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro uptake and release of natamycin Dex-b-PLA nanoparticles from model contact lens materials.
    Phan CM; Subbaraman L; Liu S; Gu F; Jones L
    J Biomater Sci Polym Ed; 2014; 25(1):18-31. PubMed ID: 24007402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of natamycin:cyclodextrin inclusion complexes and their characterization.
    Koontz JL; Marcy JE
    J Agric Food Chem; 2003 Nov; 51(24):7106-10. PubMed ID: 14611179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of natamycin and its cyclodextrin inclusion complexes in aqueous solution.
    Koontz JL; Marcy JE; Barbeau WE; Duncan SE
    J Agric Food Chem; 2003 Nov; 51(24):7111-4. PubMed ID: 14611180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro uptake and release of natamycin from conventional and silicone hydrogel contact lens materials.
    Phan CM; Subbaraman LN; Jones L
    Eye Contact Lens; 2013 Mar; 39(2):162-8. PubMed ID: 23392304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Topical Ophthalmic Natamycin Suspension for the Treatment of Fungal Keratitis.
    Cai C; Youssef AAA; Joshi PH; Varner C; Dudhipala N; Majumdar S
    J Ocul Pharmacol Ther; 2024; 40(1):67-77. PubMed ID: 38117668
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization, inclusion mode, phase-solubility and in vitro release studies of inclusion binary complexes with cyclodextrins and meglumine using sulfamerazine as model drug.
    Aloisio C; Gomes de Oliveira A; Longhi M
    Drug Dev Ind Pharm; 2014 Jul; 40(7):919-28. PubMed ID: 23627444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(hydroxyethyl methacrylate-co-methacrylated-beta-cyclodextrin) hydrogels: synthesis, cytocompatibility, mechanical properties and drug loading/release properties.
    dos Santos JF; Couceiro R; Concheiro A; Torres-Labandeira JJ; Alvarez-Lorenzo C
    Acta Biomater; 2008 May; 4(3):745-55. PubMed ID: 18291738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative.
    Jug M; Kosalec I; Maestrelli F; Mura P
    J Pharm Biomed Anal; 2011 Apr; 54(5):1030-9. PubMed ID: 21215544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-binding hydrogels of hyaluronic acid functionalized with beta-cyclodextrin.
    Zawko SA; Truong Q; Schmidt CE
    J Biomed Mater Res A; 2008 Dec; 87(4):1044-52. PubMed ID: 18257063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
    Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
    Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrospun formulation of acyclovir/cyclodextrin nanofibers for fast-dissolving antiviral drug delivery.
    Celebioglu A; Uyar T
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111514. PubMed ID: 33255070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclodextrin-containing hydrogels for contact lenses as a platform for drug incorporation and release.
    Xu J; Li X; Sun F
    Acta Biomater; 2010 Feb; 6(2):486-93. PubMed ID: 19619677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclodextrin-functionalized polyethylene and polypropylene as biocompatible materials for diclofenac delivery.
    Nava-Ortíz CA; Alvarez-Lorenzo C; Bucio E; Concheiro A; Burillo G
    Int J Pharm; 2009 Dec; 382(1-2):183-91. PubMed ID: 19716868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
    Cirri M; Bragagni M; Mennini N; Mura P
    Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxymethyl and hydrazide functionalized β-cyclodextrin derivatives: a systematic investigation of complexation behaviours with the model hydrophobic drug dexamethasone.
    Mateen R; Hoare T
    Int J Pharm; 2014 Sep; 472(1-2):315-26. PubMed ID: 24974986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posaconazole/hydroxypropyl-β-cyclodextrin host-guest system: Improving dissolution while maintaining antifungal activity.
    Tang P; Ma X; Wu D; Li S; Xu K; Tang B; Li H
    Carbohydr Polym; 2016 May; 142():16-23. PubMed ID: 26917368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-inclusion complexes between riboflavin and cyclodextrins.
    de Jesus MB; Fraceto LF; Martini MF; Pickholz M; Ferreira CV; de Paula E
    J Pharm Pharmacol; 2012 Jun; 64(6):832-42. PubMed ID: 22571261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Competing Effects of Hyaluronic and Methacrylic Acid in Model Contact Lenses.
    Weeks A; Subbaraman LN; Jones L; Sheardown H
    J Biomater Sci Polym Ed; 2012; 23(8):1021-38. PubMed ID: 21477462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol sustained release from high affinity cyclodextrin hydrogels.
    Rodriguez-Tenreiro C; Alvarez-Lorenzo C; Rodriguez-Perez A; Concheiro A; Torres-Labandeira JJ
    Eur J Pharm Biopharm; 2007 Apr; 66(1):55-62. PubMed ID: 17081737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.